Advanced search    

Search: authors:"Nadia Harbeck"

2 papers found.
Use AND, OR, NOT, +word, -word, "long phrase", (parentheses) to fine-tune your search.

15. Internationale St.-Gallen-Konsensus-Konferenz: Behandlung des frühen Mammakarzinoms

]) sowie der St. Gallen Panel Expert: Univ.-Prof. Dr. med. Jens Huober, Univ.-Prof. Dr. med. Nadia Harbeck. S3-Leitlinie [11], deren Aktualisierung vor der Fertigstellung steht, kommentiert. Die 15. St

Treatment strategies that effectively reduce early recurrence risk in postmenopausal women with endocrine-sensitive breast cancer: AIs upfront vs. switching

Several large, well-controlled clinical trials have now established that the aromatase inhibitors (AIs), including letrozole, anastrozole, and exemestane, are more effective than tamoxifen when used as adjuvant endocrine therapy in postmenopausal women with breast cancer. Yet, it is an open question as to how these drugs should be best integrated into the adjuvant treatment...